Glucagon tells the liver to break down stored glucose and release it into the bloodstream
Avoiding the rebound, therefore, lies in the GLP-1 patients ability to embrace healthier eating while on the drugs and then sustaining these new habits when they finish taking them, explains UK dietician and nutritionist, Dr Sarah Schenker
Wegovy works by mimicking the naturally occurring glucagon-like peptide-1 (GLP-1) hormone, which regulates appetite and metabolism
Insurance companies and compounding pharmacies typically decline to supply phentermine in combination with GLP-1 medications, and prescribers cite insufficient safety data
According to Harvard Health, drugs in this family help people feel fuller, slow digestion and reduce hunger signals, which can make weight loss easier when paired with diet and exercise